The board shall issue its publications that are circulated in quantity outside the executive branch in accordance with section 24-1-136. The board shall circulate its publications to all registered prescription drug outlets that will be directly affected by the publications.
Source: L. 2019: Entire title R&RE with relocations, (HB 19-1172), ch. 136, p. 1451, � 1, effective October 1.
Editor's note: This section is similar to former � 12-42.5-108 as it existed prior to 2019.